Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
US Department of Justice
Fish and Richardson
US Army
Deloitte
AstraZeneca
Chinese Patent Office
Federal Trade Commission
Boehringer Ingelheim
Harvard Business School

Generated: August 17, 2017

DrugPatentWatch Database Preview

VIBRAMYCIN Drug Profile

« Back to Dashboard

Which patents cover Vibramycin, and when can generic versions of Vibramycin launch?

Vibramycin is a drug marketed by Pfizer and is included in four NDAs.

The generic ingredient in VIBRAMYCIN is doxycycline calcium. There are twenty-seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the doxycycline calcium profile page.

Summary for Tradename: VIBRAMYCIN

Patents:0
Applicants:1
NDAs:4
Suppliers / Packagers: see list2
Bulk Api Vendors: see list31
Clinical Trials: see list3
Patent Applications: see list1,300
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:VIBRAMYCIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer
VIBRAMYCIN
doxycycline
FOR SUSPENSION;ORAL050006-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
Pfizer
VIBRAMYCIN
doxycycline hyclate
INJECTABLE;INJECTION050442-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Pfizer
VIBRAMYCIN
doxycycline hyclate
CAPSULE;ORAL050007-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Pfizer
VIBRAMYCIN
doxycycline hyclate
CAPSULE;ORAL050007-002Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
Pfizer
VIBRAMYCIN
doxycycline calcium
SUSPENSION;ORAL050480-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Accenture
Fish and Richardson
AstraZeneca
QuintilesIMS
Dow
Medtronic
Cerilliant
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot